MAP3K8

NameSynonymsFull NameRefSeq IDDescription (.pdf)IGV-img (humangenome)Sashimi-img (humangenome)UCSC-img (humangenome)IGV-img (batgenome)
MAP3K8 A8K2Q5, COT, D3DRX1, ESTF, M3K8_HUMAN, NM_005204, NP_005195, P41279, Q14275, Q5T855, Q9HC81, TPL2,Tpl-2, EST, c-COT, MEKK8 mitogen-activated protein kinase kinase kinase 8 NM_005204 pdf

Download all snapshots for IGV, UCSC and Sashimi (zip archive)

Description

Homo sapiens mitogen-activated protein kinase kinase kinase 8 (MAP3K8), transcript variant 1 gen is an oncogene that encodes a member of the serine/threonine protein kinase family. The encoded protein localizes to the cytoplasm and can activate both the MAP kinase and JNK kinase pathways. This protein was shown to activate IkappaB kinases, and thus induce the nuclear production of NF-kappaB. This protein was also found to promote the production of TNF-alpha and IL-2 during T lymphocyte activation. This gene may also utilize a downstream in-frame translation start codon, and thus produce an isoform containing a shorter N-terminus. The shorter isoform has been shown to display weaker transforming activity. Alternate splicing results in multiple transcript variants that encode the same protein. It is required for lipopolysaccharide (LPS)-induced, TLR4-mediated activation of the MAPK/ERK pathway in macrophages, thus being critical for production of the proinflammatory cytokine TNF-alpha (TNF) during immune responses. Involved in the regulation of T-helper cell differentiation and IFNG expression in T-cells. Involved in mediating host resistance to bacterial infection through negative regulation of type I interferon (IFN) production. In vitro, activates MAPK/ERK pathway in response to IL1 in an IRAK1-independent manner, leading to up-regulation of IL8 and CCL4. Transduces CD40 and TNFRSF1A signals that activate ERK in B-cells and macrophages, and thus may play a role in the regulation of immunoglobulin production. May also play a role in the transduction of TNF signals that activate JNK and NF-kappa-B in some cell types. In adipocytes, activates MAPK/ERK pathway in an IKBKB-dependent manner in response to IL1B and TNF, but not insulin, leading to induction of lipolysis. Plays a role in the cell cycle. Isoform 1 shows some transforming activity, although it is much weaker than that of the activated oncogenic variant.

The expression profiles are the same for all samples: no differential expression, few reads, most of them mapping to exons at the 3' end.

Show legend

Maximum read counts and DESeq normalized read counts for human and bat cell lines

Source Species Mapping on Mock3h Mock7h Mock23h EBOV3h EBOV7h EBOV23h MARV3h MARV7h MARV23h
Read_Max
humanH. sapiensGenome11 16 12 12 15 16 28 26 22
Read_Max
batR. aegyptiacusTranscriptome 7 13 8 9 13 16 3 18 12
Read_Max
bat_genomeR. aegyptiacusGenome 26 12 18 19 14 12 11 28 28
DESeq
humanH. sapiensGenome 167.43 235.57 203.54 188.07 187.98 281.29 255.39 271.98 272.84
DESeq
batR. aegyptiacusTranscriptome 14.44 25.51 25.43 17.48 26.19 30.51 6.56 18.35 24.62
DESeq
bat_genomeR. aegyptiacusGenome 128.91 101.31 158.44 150.1 136.17 182.76 112.45 124.49 180.66

Human Condition Comparisons

human Mock EBOV MARV FCMock_EBOV FCMock_MARV FCEBOV_MARV
3h 167.43 188.07 255.39 0.17 0.61 0.44
7h 235.57 187.98 271.98 -0.33 0.21 0.53
23h 203.54 281.29 272.84 0.47 0.42 -0.04

Human Time Point Comparisons

human 3h 7h 23h FC3h_7h FC3h_23h FC7h_23h
Mock 167.43 235.57 203.54 0.49 0.28 -0.21
Ebov 188.07 187.98 281.29 -0.0 0.58 0.58
Marv 255.39 271.98 272.84 0.09 0.1 0.0

Bat Condition Comparisons

bat Mock EBOV MARV FCMock_EBOV FCMock_MARV FCEBOV_MARV
3h 14.44 17.48 6.56 0.28 -1.14 -1.41
7h 25.51 26.19 18.35 0.04 -0.48 -0.51
23h 25.43 30.51 24.62 0.26 -0.05 -0.31

Bat Time Point Comparisons

bat 3h 7h 23h FC3h_7h FC3h_23h FC7h_23h
Mock 14.44 25.51 25.43 0.82 0.82 -0.0
Ebov 17.48 26.19 30.51 0.58 0.8 0.22
Marv 6.56 18.35 24.62 1.48 1.91 0.42